Boston Scientific (BSX) Tops Q4 EPS by 4c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Boston Scientific (NYSE: BSX) | Delayed: 45.79 +1.28 (2.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.51 | 52 Week High | $24.79 | |||
| Open | $44.72 | 52 Week Low | $15.67 | |||
| Day High | $45.88 | P/E | N/A | |||
| Day Low | $44.62 | EPS | $-0.09 | |||
| Volume | 5,782,953 | |||||
